About ACP-105 Ultima Pharmaceuticals
ACP-105 is a non-steroidal selective androgen receptor modulator (SARM) with partial agonist properties that has gained attention in preclinical research settings. Synthesised as a potent alternative to traditional anabolic compounds, this selective modulator demonstrates comparable anabolic effects to testosterone propionate at lower concentrations in animal models. Researchers at Stroid UK Shop investigate ACP-105’s unique receptor binding profile, which exhibits tissue-selective activity in muscle and bone tissue while demonstrating reduced androgenic effects in prostate models. This Ultima Pharmaceuticals compound represents an important research tool for scientists examining selective androgen receptor modulation pathways.
Laboratory Applications
Research teams utilise ACP-105 to examine selective androgen receptor activation mechanisms in controlled laboratory environments. Preclinical studies have evaluated this compound’s effects on bone density and muscle mass development in animal models, providing valuable insights into tissue-selective androgenic activity. The compound’s partial agonist characteristics make it particularly valuable for researchers studying other drugs with selective receptor modulation properties. Scientists analyse ACP-105’s molecular interactions alongside established research compounds from our SARMs collection to better understand androgen receptor selectivity patterns. Laboratory protocols often incorporate this modulator when investigating comparative binding affinity studies with related compounds available through our peptides research catalogue.
Technical Specifications
| Parameter | Value |
|---|---|
| CAS Number | 899821-23-9 |
| Molecular Formula | C₁₆H₁₉ClN₂O |
| Molecular Weight | 290.79 g/mol |
| Classification | Non-steroidal SARM |
| Mechanism | Partial androgen receptor agonist |
| Storage Temperature | Room temperature |
| Manufacturer | Ultima Pharmaceuticals |
Research Compliance
This ACP-105 research compound is manufactured by Ultima Pharmaceuticals exclusively for in-vitro laboratory research applications. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, appropriate storage conditions, and compliance with institutional research guidelines. Purchase restricted to qualified research institutions and licensed laboratories conducting legitimate scientific studies.
